## Studies that fit the criteria

### Haris's Studies 

GSE138531: 3 stenotic vs 3 sclerotic human aortic valve samples. Do one as a control and one as treatment. 

GSE141910: Left ventricular transcriptomes of non-failing healthy donors, Peripartum cardiomyopathy (PPCM), Hypertrophic cardiomyopathy (HCM) and Dilated cardiomyopathy (DCM) samples.

GSE143148: Differentiated medium vs full medium. (RNA Samples only).

GSE55492: Control vs Calcified tricuspid aortic valve.

GSE60292: Unstimulated control cardiomyocytes vs ET-1 stimulated cardiomyocytes.

GSE65446: Controls vs heart mRNA profiles from dilated cardiomyopathy diagnosed patients who had undergone heart transplant.

GSE65705: 16 ST-segment elevation myocardial infarction (STEMI), 16 non-STEMI (NSTEMI), and 2 controls.

GSE67844: Cardiomyoctyes treated with siRNA knockdown (scrambled control, PANCR, PITX2c) in triplicate and RNA and smallRNAs extracted for sequencing.

GSE76717: Calcified tricuspid aortic valves vs controls.

GSE85565: Control vs TCF21 overexpression.

GSE36759: Right ventricular small RNA-seq profiles from 22 patients with Tetralogy of Fallot and small RNA-seq profiles from the left and right ventricle of 4 healthy unaffected individuals.

GSE36761: Right ventricular mRNA-seq profiles from 22 patients with Tetralogy of Fallot and small RNA-seq profiles from the left and right ventricle of 4 healthy unaffected individuals. 

GSE89714: Control vs heart tissue of hypertrophic cardiomyopathy patients.

### Chelsia's Studies

GSE95120: Control vs Cardiac stromal cells from Arrhythmogenic cardiomyopathy patients.

GSE95390: Human induced pluripotent stem cells to generate cardiac progenitor cells.

GSE96975: Control(basal) vs Cardiac fibroblasts treated with IL11 vs Cardiac fibroblasts treated with TGFB1.

GSE98941: Control vs polyI:C treated cardiac progenitors vs TGFbeta treated cardiac progenitors.

GSE99321: Controls vs LV of pediatric idiopathic dilated cardiomyopathy patients.

GSE108157: LV samples - ischemic vs non-ischemic heart failure.

GSE44461: non-silencing control versus TCF21 knockdown.

GSE120567: Myocarditis vs DCM patients.

GSE120852: Left and Right Ventricles of 15 individuals, 5 control, 5 left-sided Heart Failure, 5 bi-ventricular Heart Failure (WIPI1).

GSE121559: Familial control vs human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient. 

GSE46224: RNA and non-coding RNA transcriptome profiling in human failing and non-failing control hearts. 5 groups of samples: NF, ICM, NICM, ICM+LVAD, NICM+LVAD

GSE128188: Control vs Atrial fibrillation.

GSE48166: Control vs Ischemic cardiomyopathy.

## Studies that do not fit the criteria

GSE138837: Less than 3 replicates.

GSE126488: Study explores human embryo transcriptomics datasets and expression of transcripts for insuling and insulin growth factor 1 (IGF1) receptors.

GSE139335: Study explores neuroendocrine prostate cancer.

GSE139685: Study explores keratinocytes in the skin.

GSE53080: Less than 3 replicates.

GSE53296: Less than 3 replicates.

GSE55939: Study explores Turner syndrome.

GSE56648: Less than 3 replicates.

GSE57012: Study explores psoriasis.

GSE57896: Study explores white-to-brown metabolic conversion of human adipocytes.

GSE60217: Less than 3 replicates.

GSE63055: Study explores Williams Beuren Syndrome (WBS) and 7q microduplication syndrome (7dupASD).

GSE63161: Less than 3 replicates.

GSE64942: Study explores germ cells.

GSE65523: Less than 3 replicates.

GSE65752: Study explores Epstein-Barr virus.

GSE65761: Less than 3 replicates.

GSE67488: Less than 3 replicates.

GSE67489: Less than 3 replicates.

GSE70668: Study explores oncogene-induced senescence.

GSE71613: Less than 3 replicates.

GSE71710: Less than 3 replicates.

GSE72379: Less than 3 replicates.

GSE72696: Less than 3 replicates.

GSE73210: Less than 3 replicates.

GSE73370: Study explores breast cancer.

GSE73478: Study explores immune response to bacterial macrophages (miRNA). 

GSE73502: Study explores immune response to bacterial macrophages (mRNA).

GSE74142: Less than 3 replicates.

GSE74235: Hydroxychloroquine inhibits responses to group A streptococcus that can lead to development of rheumatic heart disease.

GSE74941: Less than 3 replicates.

GSE74716: Less than 3 replicates.

GSE74798: Study explores prostate cancer cells.

GSE76712: Lacks control group.

GSE77784: Study not relevant to heart disease.

GSE80333: Study explores breast cancer cells.

GSE81046: Study explores immune response to pathogens.

GSE81254: Study explores samples of ocular tissue.

GSE32689: Less than 3 replicates.

GSE81608: Study explores pancreatic islet cells.

GSE81809: Sample description unclear.

GSE83245: Study explores rectal mucosal transcriptome.

GSE83410: Profiling AGO2-associated RNAs in cardiac tissues (6 samples differing etiologies). Continous variable.

GSE84536: Study explores liver tissue effected by dengue hemorrhagic fever.

GSE84814: Study explores glucose effects on early heart development.

GSE85623: Less than 3 replicates.

GSE86316: Study explores breast cancer cells.

GSE87626: Study explores breast cancer cells.

GSE89843: Study explores lung cancer. 

GSE89972: Less than 3 replicates.

GSE92447: Less than 3 replicates.

GSE92616: Less than 3 replicates.

GSE92724: Study explores diabetes (mentions heart disease).

GSE93235: Study explores HeLa cells.

GSE93740: Study explores breast cancer.

GSE94533: Study explores ovarian cancer.

GSE95155: Study not relevant to heart disease.

GSE85632: Less than 3 replicates.

GSE98206: Study explores lymphocytic leukemia.

GSE99349: Study explores cocaine use disorder.

GSE100075: Study explores breast cancer.

GSE101788: Study explores leukemia.

GSE101913: Study not relevant to heart disease.

GSE102934: Study not relevant to heart disease.

GSE103327: Study explores hepatocellular carcinoma. 

GSE107923: Less than 3 replicates.

GSE108763: Study not relevant to heart disease.

GSE113117: Less than 3 replicates.

GSE115099: Study explores skin disease.

GSE116744: Study explores breast cancer.

GSE45722: Less than 3 replicates.

GSE121578: Less than 3 replicates.

GSE121699: Less than 3 replicates.

GSE121893: Less than 3 replicates.

GSE47399: Study not relevant to heart disease.

GSE49716: Less than 3 replicates.

## Haris's Contrasts

SRP224657: aortic valve stenosis versus aortic valve sclerosis: stenosis; SRX6959190, SRX6959191, SRX6959192: sclerosis; SRX6959193, SRX6959194, SRX6959195;

SRP237337: RNA sequencing of left ventricle from non-failing healthy controls versus left ventricle from peripartum cardiomyopathy (PPCM): control; SRX7354049, SRX7354050, SRX7354051, SRX7354319, SRX7354320, SRX7354321, SRX7354322, SRX7354323, SRX7354324, SRX7354325, SRX7354326, SRX7354327, SRX7354328, SRX7354329, SRX7354330, SRX7354331, SRX7354332, SRX7354333, SRX7354334, SRX7354335, SRX7354081, SRX7354086, SRX7354087, SRX7354089, SRX7354093, SRX7354094, SRX7354096, SRX7354099, SRX7354100, SRX7354102, SRX7354103, SRX7354104, SRX7354105, SRX7354107, SRX7354109, SRX7354110, SRX7354111, SRX7354112, SRX7354113, SRX7354116, SRX7354117, SRX7354119, SRX7354120, SRX7354122, SRX7354123, SRX7354124, SRX7354125, SRX7354126, SRX7354127, SRX7354129, SRX7354130, SRX7354131, SRX7354132, SRX7354134, SRX7354135, SRX7354137, SRX7354138, SRX7354139, SRX7354140, SRX7354142, SRX7354143, SRX7354144, SRX7354145, SRX7354148, SRX7354149, SRX7354156, SRX7354158, SRX7354164, SRX7354165, SRX7354170, SRX7354172, SRX7354176, SRX7354177, SRX7354178, SRX7354179, SRX7354180, SRX7354181, SRX7354182, SRX7354184, SRX7354185, SRX7354188, SRX7354189, SRX7354190, SRX7354192, SRX7354193, SRX7354194, SRX7354195, SRX7354196, SRX7354197, SRX7354199, SRX7354200, SRX7354201, SRX7354203, SRX7354204, SRX7354209, SRX7354210, SRX7354211, SRX7354213, SRX7354214, SRX7354215, SRX7354216, SRX7354217, SRX7354218, SRX7354219, SRX7354224, SRX7354226, SRX7354227, SRX7354229, SRX7354230, SRX7354231, SRX7354233, SRX7354234, SRX7354236, SRX7354237, SRX7354239, SRX7354241, SRX7354242, SRX7354243, SRX7354244, SRX7354245, SRX7354246, SRX7354247, SRX7354248, SRX7354249, SRX7354251, SRX7354255, SRX7354256, SRX7354257, SRX7354258, SRX7354259, SRX7354264, SRX7354265, SRX7354266, SRX7354267, SRX7354268, SRX7354269, SRX7354270, SRX7354271, SRX7354272, SRX7354273, SRX7354274, SRX7354279, SRX7354280, SRX7354281, SRX7354282, SRX7354283, SRX7354285, SRX7354287, SRX7354289, SRX7354290, SRX7354293, SRX7354295, SRX7354300, SRX7354303, SRX7354306, SRX7354308, SRX7354309, SRX7354311, SRX7354316, SRX7354307, SRX7354151, SRX7354084, SRX7354205, SRX7354206, SRX7354207, SRX7354208: PPCM; SRX7354336, SRX7354337, SRX7354357, SRX7354118, SRX7354146, SRX7354163;

SRP237337: RNA sequencing of left ventricle from non-failing healthy controls versus left ventricle from hypertrophic cardiomyopathy (HCM): control; SRX7354049, SRX7354050, SRX7354051, SRX7354319, SRX7354320, SRX7354321, SRX7354322, SRX7354323, SRX7354324, SRX7354325, SRX7354326, SRX7354327, SRX7354328, SRX7354329, SRX7354330, SRX7354331, SRX7354332, SRX7354333, SRX7354334, SRX7354335, SRX7354081, SRX7354086, SRX7354087, SRX7354089, SRX7354093, SRX7354094, SRX7354096, SRX7354099, SRX7354100, SRX7354102, SRX7354103, SRX7354104, SRX7354105, SRX7354107, SRX7354109, SRX7354110, SRX7354111, SRX7354112, SRX7354113, SRX7354116, SRX7354117, SRX7354119, SRX7354120, SRX7354122, SRX7354123, SRX7354124, SRX7354125, SRX7354126, SRX7354127, SRX7354129, SRX7354130, SRX7354131, SRX7354132, SRX7354134, SRX7354135, SRX7354137, SRX7354138, SRX7354139, SRX7354140, SRX7354142, SRX7354143, SRX7354144, SRX7354145, SRX7354148, SRX7354149, SRX7354156, SRX7354158, SRX7354164, SRX7354165, SRX7354170, SRX7354172, SRX7354176, SRX7354177, SRX7354178, SRX7354179, SRX7354180, SRX7354181, SRX7354182, SRX7354184, SRX7354185, SRX7354188, SRX7354189, SRX7354190, SRX7354192, SRX7354193, SRX7354194, SRX7354195, SRX7354196, SRX7354197, SRX7354199, SRX7354200, SRX7354201, SRX7354203, SRX7354204, SRX7354209, SRX7354210, SRX7354211, SRX7354213, SRX7354214, SRX7354215, SRX7354216, SRX7354217, SRX7354218, SRX7354219, SRX7354224, SRX7354226, SRX7354227, SRX7354229, SRX7354230, SRX7354231, SRX7354233, SRX7354234, SRX7354236, SRX7354237, SRX7354239, SRX7354241, SRX7354242, SRX7354243, SRX7354244, SRX7354245, SRX7354246, SRX7354247, SRX7354248, SRX7354249, SRX7354251, SRX7354255, SRX7354256, SRX7354257, SRX7354258, SRX7354259, SRX7354264, SRX7354265, SRX7354266, SRX7354267, SRX7354268, SRX7354269, SRX7354270, SRX7354271, SRX7354272, SRX7354273, SRX7354274, SRX7354279, SRX7354280, SRX7354281, SRX7354282, SRX7354283, SRX7354285, SRX7354287, SRX7354289, SRX7354290, SRX7354293, SRX7354295, SRX7354300, SRX7354303, SRX7354306, SRX7354308, SRX7354309, SRX7354311, SRX7354316, SRX7354307, SRX7354151, SRX7354084, SRX7354205, SRX7354206, SRX7354207, SRX7354208: HCM; SRX7354338, SRX7354345, SRX7354390, SRX7354399, SRX7354408, SRX7354409, SRX7354412, SRX7354053, SRX7354055, SRX7354071, SRX7354080, SRX7354133, SRX7354141, SRX7354159, SRX7354173, SRX7354174, SRX7354183, SRX7354220, SRX7354221, SRX7354228, SRX7354232, SRX7354240, SRX7354252, SRX7354254, SRX7354294, SRX7354313, SRX7354314, SRX7354202;

SRP237337: RNA sequencing of left ventricle from non-failing healthy controls versus left ventricle from dilated cardiomyopathy (DCM): control; SRX7354049, SRX7354050, SRX7354051, SRX7354319, SRX7354320, SRX7354321, SRX7354322, SRX7354323, SRX7354324, SRX7354325, SRX7354326, SRX7354327, SRX7354328, SRX7354329, SRX7354330, SRX7354331, SRX7354332, SRX7354333, SRX7354334, SRX7354335, SRX7354081, SRX7354086, SRX7354087, SRX7354089, SRX7354093, SRX7354094, SRX7354096, SRX7354099, SRX7354100, SRX7354102, SRX7354103, SRX7354104, SRX7354105, SRX7354107, SRX7354109, SRX7354110, SRX7354111, SRX7354112, SRX7354113, SRX7354116, SRX7354117, SRX7354119, SRX7354120, SRX7354122, SRX7354123, SRX7354124, SRX7354125, SRX7354126, SRX7354127, SRX7354129, SRX7354130, SRX7354131, SRX7354132, SRX7354134, SRX7354135, SRX7354137, SRX7354138, SRX7354139, SRX7354140, SRX7354142, SRX7354143, SRX7354144, SRX7354145, SRX7354148, SRX7354149, SRX7354156, SRX7354158, SRX7354164, SRX7354165, SRX7354170, SRX7354172, SRX7354176, SRX7354177, SRX7354178, SRX7354179, SRX7354180, SRX7354181, SRX7354182, SRX7354184, SRX7354185, SRX7354188, SRX7354189, SRX7354190, SRX7354192, SRX7354193, SRX7354194, SRX7354195, SRX7354196, SRX7354197, SRX7354199, SRX7354200, SRX7354201, SRX7354203, SRX7354204, SRX7354209, SRX7354210, SRX7354211, SRX7354213, SRX7354214, SRX7354215, SRX7354216, SRX7354217, SRX7354218, SRX7354219, SRX7354224, SRX7354226, SRX7354227, SRX7354229, SRX7354230, SRX7354231, SRX7354233, SRX7354234, SRX7354236, SRX7354237, SRX7354239, SRX7354241, SRX7354242, SRX7354243, SRX7354244, SRX7354245, SRX7354246, SRX7354247, SRX7354248, SRX7354249, SRX7354251, SRX7354255, SRX7354256, SRX7354257, SRX7354258, SRX7354259, SRX7354264, SRX7354265, SRX7354266, SRX7354267, SRX7354268, SRX7354269, SRX7354270, SRX7354271, SRX7354272, SRX7354273, SRX7354274, SRX7354279, SRX7354280, SRX7354281, SRX7354282, SRX7354283, SRX7354285, SRX7354287, SRX7354289, SRX7354290, SRX7354293, SRX7354295, SRX7354300, SRX7354303, SRX7354306, SRX7354308, SRX7354309, SRX7354311, SRX7354316, SRX7354307, SRX7354151, SRX7354084, SRX7354205, SRX7354206, SRX7354207, SRX7354208: DCM; SRX7354339, SRX7354340, SRX7354341, SRX7354342, SRX7354343, SRX7354344, SRX7354346, SRX7354347, SRX7354348, SRX7354349, SRX7354350, SRX7354351, SRX7354352, SRX7354353, SRX7354354, SRX7354355, SRX7354358, SRX7354359, SRX7354360, SRX7354361, SRX7354363, SRX7354364, SRX7354365, SRX7354366, SRX7354367, SRX7354368, SRX7354369, SRX7354370, SRX7354371, SRX7354372, SRX7354373, SRX7354374, SRX7354375, SRX7354376, SRX7354377, SRX7354378, SRX7354379, SRX7354380, SRX7354381, SRX7354382, SRX7354383, SRX7354384, SRX7354385, SRX7354386, SRX7354387, SRX7354388, SRX7354389, SRX7354391, SRX7354392, SRX7354393, SRX7354394, SRX7354395, SRX7354396, SRX7354397, SRX7354398, SRX7354400, SRX7354401, SRX7354402, SRX7354403, SRX7354404, SRX7354405, SRX7354406, SRX7354407, SRX7354410, SRX7354411, SRX7354413, SRX7354414, SRX7354052, SRX7354054, SRX7354056, SRX7354057, SRX7354058, SRX7354059, SRX7354060, SRX7354061, SRX7354062, SRX7354063, SRX7354064, SRX7354065, SRX7354066, SRX7354067, SRX7354068, SRX7354069, SRX7354070, SRX7354072, SRX7354073, SRX7354074, SRX7354075, SRX7354076, SRX7354077, SRX7354078, SRX7354079, SRX7354082, SRX7354083, SRX7354085, SRX7354088, SRX7354090, SRX7354091, SRX7354092, SRX7354095, SRX7354097, SRX7354098, SRX7354101, SRX7354106, SRX7354108, SRX7354114, SRX7354115, SRX7354121, SRX7354128, SRX7354136, SRX7354147, SRX7354150, SRX7354152, SRX7354153, SRX7354155, SRX7354157, SRX7354160, SRX7354161, SRX7354162, SRX7354167, SRX7354168, SRX7354169, SRX7354171, SRX7354175, SRX7354186, SRX7354187, SRX7354191, SRX7354198, SRX7354212, SRX7354222, SRX7354223, SRX7354235, SRX7354238, SRX7354250, SRX7354253, SRX7354260, SRX7354261, SRX7354262, SRX7354263, SRX7354275, SRX7354276, SRX7354277, SRX7354278, SRX7354284, SRX7354286, SRX7354288, SRX7354291, SRX7354292, SRX7354296, SRX7354297, SRX7354298, SRX7354299, SRX7354301, SRX7354302, SRX7354304, SRX7354305, SRX7354310, SRX7354312, SRX7354315, SRX7354317, SRX7354318, SRX7354166, SRX7354356, SRX7354362, SRX7354225, SRX7354154;

SRP239802: RNA-SEQ of HUVECS (human umbilical vein endothelial cells) in full-(FM) versus differentiation medium (DM): FM; SRX7513703, SRX7513704, SRX7513705, SRX7513706: DM; SRX7513699, SRX7513700, SRX7513701, SRX7513702; 

SRP039338: non-calcified tricuspid valve versus calcified tricuspid valve: non-calcified; SRX480424, SRX480425, SRX480426, SRX480427, SRX480428, SRX480429, SRX480430, SRX480431, SRX480432, SRX480433: calcified; SRX480415, SRX480416, SRX480417, SRX480418, SRX480419, SRX480420, SRX480421, SRX480422, SRX480423;

SRP045420: human induced pluripotent stem cell-derived control cardiomyocytes versus human induced pluripotent stem cell-derived ET-1 (endothelin 1) stimulated cardiomyocytes: control; SRX674306, SRX674308, SRX674310: ET-1 stimulated; SRX674307, SRX674309, SRX6743011;

SRP052978: control vs dilated cardiomyopathy diagnosed patients who had undergone heart transplant: control; SRX860719, SRX860720, SRX860721, SRX860722: dilated cardiomyopathy; SRX860723, SRX860724, SRX860725, SRX860726, SRX860727, SRX860728;

SRP053296: non myocardial infarction control versus patients with non-ST-segment elevation myocardial infarction (non-STEMI): control; SRX868371, SRX868372: non-STEMI; SRX868339, SRX868340, SRX868341, SRX868342, SRX868345, SRX868346, SRX868347, SRX868348, SRX868349, SRX868350, SRX868351, SRX868352, SRX868354, SRX868356, SRX868357, SRX868359;

SRP053296: non myocardial infarction control versus patients with ST-segment elevation myocardial infarction (STEMI): control; SRX868371, SRX868372: STEMI; SRX868343, SRX868344, SRX868353, SRX868355, SRX868358, SRX868360, SRX868361, SRX868362, SRX868363, SRX868364, SRX868365, SRX868366, SRX868367, SRX868368, SRX868369, SRX868370;

SRP053296: patients with non-ST-segment elevation myocardial infarction (non-STEMI) versus ST-segment elevation myocardial infarction (STEMI): non-STEMI; SRX868339, SRX868340, SRX868341, SRX868342, SRX868345, SRX868346, SRX868347, SRX868348, SRX868349, SRX868350, SRX868351, SRX868352, SRX868354, SRX868356, SRX868357, SRX868359: STEMI; SRX868343, SRX868344, SRX868353, SRX868355, SRX868358, SRX868360, SRX868361, SRX868362, SRX868363, SRX868364, SRX868365, SRX868366, SRX868367, SRX868368, SRX868369, SRX868370;

SRP057147: RNA expression of H9 derived cardiomyocytes - scrambled control versus siRNA-mediated knockdown of PANCR: scrambled control; SRX994674, SRX994675, SRX994676: siRNA knockdown PANCR; SRX994677, SRX994679, SRX994680;

SRP057147: RNA expression of H9 derived cardiomyocytes - scrambled control versus siRNA-mediated knockdown of PITX2: scrambled control; SRX994674, SRX994675, SRX994676: siRNA knockdown PITX2; SRX994681, SRX994682, SRX994683;

SRP057147: RNA expression of H9 derived cardiomyocytes - siRNA-mediated knockdown of PANCR versus siRNA-mediated knockdown of PITX2: siRNA knockdown PANCR; SRX994677, SRX994679, SRX994680: siRNA knockdown PITX2; SRX994681, SRX994682, SRX994683;

SRP057147: smallRNA expression of H9 derived cardiomyocytes - scrambled control versus siRNA-mediated knockdown of PANCR: scrambled control; SRX994684, SRX994685, SRX994686: siRNA knockdown PANCR; SRX994687, SRX994688, SRX994689; 

SRP057147: smallRNA expression of H9 derived cardiomyocytes - scrambled control versus siRNA-mediated knockdown of PITX2: scrambled control; SRX994684, SRX994685, SRX994686: siRNA knockdown PITX2; SRX994690, SRX994691, SRX994692;

SRP057147: smallRNA expression of H9 derived cardiomyocytes - siRNA-mediated knockdown of PANCR versus siRNA-mediated knockdown of PITX2: siRNA knockdown PANCR; SRX994687, SRX994688, SRX994689: siRNA knockdown PITX2; SRX994690, SRX994691, SRX994692;

SRP068292: normal aortic tricuspid valve control versus calcified aortic tricuspid valve: control; SRX1526945, SRX1526946, SRX1526947, SRX1526948, SRX1526949, SRX1526950, SRX1526951, SRX1526952, SRX1526953: calcified aortic tricuspid valve; SRX1526936, SRX1526937, SRX1526938, SRX1526939, SRX1526940, SRX1526941, SRX1526942, SRX1526943, SRX1526944

SRP076625 ??? transcriptome map of microRNA targeting events in cardiomyopathy patients:  SRX1848219, SRX1848220, SRX1848221, SRX1848222, SRX1848223, SRX1848224

SRP081577: control vs TCF21 overexpression in human coronary artery smooth muscle cells: control; SRX2018562, SRX2018563, SRX2018564, SRX2018565: TCF21 overexpression; SRX2018566, SRX2018567, SRX2018568, SRX2018569;

SRP011923: smallRNA profiles of healthy right verntricle control versus Tetralogy of Fallot (TOF) right ventricle: control; SRX131376, SRX131378, SRX131380, SRX131382: TOF; SRX131383, SRX131384!!!, SRX131385, SRX131386, SRX131387, SRX131388, SRX131389, SRX131390, SRX131391, SRX131392, SRX131393, SRX131394, SRX131395, SRX131396, SRX131397, SRX131398, SRX131399, SRX131400, SRX131401, SRX131402, SRX131403, SRX131404, SRX131405, SRX131406;

SRP011924: mRNA profiles of healthy right verntricle control versus Tetralogy of Fallot (TOF) right ventricle: control; SRX131414!!!, SRX131416, SRX131418, SRX131420: TOF; SRX131421, SRX131422, SRX131423, SRX131424, SRX131425, SRX131426, SRX131427, SRX131428, SRX131429, SRX131430, SRX131431, SRX131432, SRX131433, SRX131434, SRX131435, SRX131436, SRX131437, SRX131438, SRX131439, SRX131440, SRX131441, SRX131442;

SRP093240: gene expression differential - normal control versus hypertrophic cardiomyopathy (HCM): control; SRX2339810, SRX2339811, SRX2339812, SRX2339813: HCM; SRX2339805, SRX2339806, SRX2339807, SRX2339808, SRX2339809;

### Chelsia's contrasts

SRP026208:left ventricular control myocardial samples versus ischemic cardiomyopathy (ICM) sample: control; SRX312124, SRX312125, SRX312126,	SRX312127, SRX312128, SRX312129, SRX312130,	SRX312131, SRX312132, SRX312133, SRX312134, SRX312135, SRX312136, SRX312137,	SRX312138, SRX312139: ICM samples; SRX312140, SRX312141,	SRX312142, SRX312143, SRX312144, SRX312145,	SRX3121246,	SRX312147, SRX312148,	SRX312149, SRX312150,	SRX312151, SRX312152, SRX312153, SRX312154,	SRX312155;

SRP188219:sinus rythm in left atrium versus right atrium:left atrium; SRX5509125, SRX5509127, SRX5509129, SRX5509131, SRX5509133:right atrium; SRX5509126, SRX5509128, SRX5509130, SRX5509132, SRX5509134; sex

SRP188219:atrial fibrillation in left atrium versus right atrium:left atrium;SRX5509135, SRX5509137, SRX5509139, SRX5509141, SRX5509143:right atrium; SRX5509136, SRX5509138, SRX5509140, SRX5509142, SRX5509144; sex 

SRP188219: sinus rythm in the left atrium versus atrial fibrilation in the left atrium:sinus rythm;	SRX5509127, SRX5509129,	SRX5509131,	SRX5509132,	SRX5509133:atrial fibrillation;	SRX5509135,	SRX5509137,	SRX5509139,	SRX5509141,	SRX5509142; sex

SRP188219:sinus rythm in the right atrium versus atrial fibrilation in the right atrium: sinus rythm; SRX5509126, SRX5509128, SRX5509130, SRX5509132, SRX5509134:atrial fibrillation; SRX5509136, SRX5509138, SRX5509140, SRX5509141, SRX5509142; sex

SRP021193: non-failing (NF) in left ventricle apex tissue versus ischemic cardiomyopathy (ICM) using RNASeq:NF; SRX268708, SRX268709, SRX268710, SRX268711, SRX268712, SRX268713, SRX268714, SRX268715:ICM; SRX268716, SRX268717, SRX268718, SRX268719, SRX268720, SRX268721, SRX268722, SRX268723; LVAD support

SRP021193: non-failing (NF) in left ventricle apex tissue versus non-ischemic cardiomyopathy (NICM) using RNASeq:NF; SRX268708, SRX268709, SRX268710, SRX268711, SRX268712, SRX268713, SRX268714, SRX268715:NICM; SRX268724, SRX268725,	SRX268726,	SRX268727,	SRX268728,	SRX268729,	SRX268730,	SRX268731; LVAD support

SRP021193: ischemic cardiomyopathy (ICM) versus non-ischemic cardiomyopathy (NICM) using RNASeq:ICM; SRX268716, SRX268717, SRX268718, SRX268719, SRX268720, SRX268721, SRX268722, SRX268723:NICM; SRX268724, SRX268725,	SRX268726,	SRX268727,	SRX268728,	SRX268729,	SRX268730,	SRX268731; LVAD support

SRP021193:ischemic cardiomyopathy (ICM) versus ischemic cardiomyopathy post left ventricular assist device (ICM+LVAD):ICM; SRX268716, SRX268717, SRX268718, SRX268719, SRX268720, SRX268721, SRX268722, SRX268723:ICM+LVAD; SRX268732, SRX268733, SRX268734, SRX268735, SRX268736, SRX268737, SRX268738, SRX268739; LVAD support

SRP021193:non-ischemic cardiomyopathy(NICM) versus non-ischemic cardiomyopathy post left ventricular assist device (NICM+LVAD):NICM; SRX268724, SRX268725,	SRX268726,	SRX268727,	SRX268728,	SRX268729,	SRX268730,	SRX268731:NICM+LVAD; SRX268740, SRX268741,SRX268742, SRX268743, SRX268744, SRX268745, SRX268746,	SRX268747

SRP166274:human induced pluripotent stem cell-derived cardiomyocytes from a familial control versus cardiomyopathy:familial control;	SRX4910761,	SRX4910762,	SRX4910763: cardiomyopathy;	SRX4910764,	SRX4910765,	SRX4910766; paired;

SRP163478: right ventricle of non-failing control versus right ventricle of left ventricular heart failure (LV-HF): control;	SRX4799399,	SRX4799401,	SRX4799402, SRX4799403, SRX4799404: LV-HF; SRX4799404, SRX4799405, SRX4799406, SRX4799407, SRX4799408;

SRP163478: right ventricle of non-failing control versus right ventricle of biventricular heart failure (BiV-HF): control; SRX4799399, SRX4799401, SRX4799402, SRX4799403, SRX4799404: BiV-HF; SRX4799409, SRX4799410, SRX4799411, SRX4799412, SRX4799413;

SRP163478:right ventricle of left ventricular heart failure (LV-HF) versus right ventricle of biventricular heart failure (BiV-HF): LV-HF; SRX4799404, SRX4799405, SRX4799406, SRX4799407, SRX4799408: BiV-HF; SRX4799409, SRX4799410, SRX4799411, SRX4799412, SRX4799413;

SRP163478: left ventricle of non-failing control versus left ventricle of left ventricular heart failure (LV-HF): control;	SRX4799414,	SRX4799415,	SRX4799416,	SRX4799417,	SRX4799418: LV-HF; SRX4799419, SRX4799420,	SRX4799421,	SRX4799422,	SRX4799423;

SRP163478: left ventricle of non-failing control versus left ventricle of biventricular heart failure (BiV-HF): control;	SRX4799414,	SRX4799415,	SRX4799416,	SRX4799417, SRX4799418: BiV-HF; SRX4799424, SRX4799425, SRX4799426, SRX4799427, SRX4799428;

SRP163478: left ventricle of left ventricular heart failure (LV-HF) versus left ventricle of biventricular heart failure (BiV-HF): LV-HF;	SRX4799419,	SRX4799420,	SRX4799421,	SRX4799422, SRX4799423: BiV-HF; SRX4799424, SRX4799425, SRX4799426, SRX4799427, SRX4799428;

SRP162743:patients with a non-inflammatory dilated cardiomyopathy (DCM) versus patients with acute myocarditis:DCM;	SRX4744907,	SRX4744908,	SRX4744909,	SRX4744910,SRX4744911,	SRX4744912,	SRX4744913,	SRX4744914,	SRX4744915,	SRX4744916,	SRX4744917:myocarditis;SRX4744918,SRX4744919,SRX4744920,SRX4744921,SRX4744922;age

SRP018779:non-silencing control versus TCF21 knockdown:non-silencing control;	SRX243750,	SRX243751,	SRX243752:TCF21;SRX243753,SRX243754,SRX243755;

SRP126861:left ventricle samples in non-ischemic cardiomyopathy (NICM) versus ischemic cardiomyopathy (ISCH):NICM;SRX3474755,SRX3474756,SRX3474758,SRX3474760,SRX3474761,SRX3474762:ISCH;	SRX3474757,SRX3474759,SRX3474763,	SRX3474764,SRX3474765; sex, race

SRP108065:control versus left ventricle of pediatric idiopathic dilated cardiomyopathy patients:control;SRX2858506,SRX2858508,	SRX2858509,	SRX2858511,SRX2858512, SRX2858513,	SRX2858517:idopathic dilated cardiomyopathy;SRX2858505,SRX2858507,	SRX2858510,	SRX2858514,	SRX2858515,SRX2858516,	SRX2858518;

SRP107288:Control versus polyI:C treated cardiac progenitors:control;SRX2827481,SRX2827482,	SRX2827483:polyI:C;SRX2827487,SRX2827488,SRX2827489;

SRP107288:Control versus TGFbeta treated cardiac progenitors:control;SRX2827481,SRX2827482,	SRX2827483:TGFbeta;SRX2827484,SRX2827485,	SRX2827486;

SRP107288:polyI:C treated cardiac progenitors versus TGFbeta treated cardiac progenitors:polyI:C;SRX2827487,SRX2827488,SRX2827489:TGFbeta;SRX2827484,SRX2827485,	SRX2827486;

SRP102374:Control basal versus cardiac fibroblasts treated with IL11:control;SRX2664166,	SRX2664168,	SRX2664170,SRX2664172,SRX2664174,SRX2664176,	SRX2664178,SRX2664180,SRX2664182,SRX2664184:IL11;SRX2664167,SRX2664169,SRX2664171,	SRX2664173,SRX2664175,SRX2664177,SRX2664179,SRX2664181,SRX2664183,SRX2664185;

SRP102374:Control basal versus cardiac fibroblasts treated with TGFB1:control;SRX2664166,	SRX2664168,	SRX2664170,SRX2664172,SRX2664174,SRX2664176,	SRX2664178,SRX2664180,SRX2664182,SRX2664184:TGFB1;SRX2664186,SRX2664187,SRX2664188,SRX2664189;

SRP102374:cardiac fibroblasts treated with IL11 versus cardiac fibroblasts treated with TGFB1: IL11;SRX2664167,SRX2664169,SRX2664171,	SRX2664173,SRX2664175,SRX2664177,SRX2664179,SRX2664181,SRX2664183,SRX2664185:TGFB1;SRX2664186,SRX2664187,SRX2664188,SRX2664189;

SRP100748:human induced pluripotent stem cells(hiPSCs) versus DMSO treated hiPSCs:hiPSCs;	SRX2592092,	SRX2592093,SRX2592094,SRX2592095:DMSO;SRX2592100,SRX2592101,SRX2592102,SRX2592103;

SRP100748:human induced pluripotent stem cells(hiPSCs) versus ISX-9 treated hiPSCs:hiPSCs;	SRX2592092,	SRX2592093,SRX2592094,SRX2592095:ISX-9;SRX2592096,SRX2592097,SRX2592098,SRX2592099;

SRP100748:DMSO treated hiPSCs versus ISX-9 treated hiPSCs:DMSO;SRX2592100,SRX2592101,SRX2592102,SRX2592103:ISX-9;SRX2592096,SRX2592097,SRX2592098,SRX2592099;

SRP100426:control vs cardiac stromal cells from arrhythmogenic cardiomyopathy patients(ACM):control;SRX2578750,SRX2578751,SRX2578752:ACM;SRX2578747,SRX2578748,SRX2578749;sex
